Direct-to-consumer ads may be beneficial for aromatase inhibitors

  • PDF / 143,230 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 6 Downloads / 278 Views

DOWNLOAD

REPORT

73-5503/10/0668-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

PharmacoEconomics & Outcomes News 8 Dec 2012 No. 668

1

Data Loading...

Recommend Documents
Clinical Pharmacokinetics of Aromatase Inhibitors and Inactivators

211 30 148KB

Resistance to Aromatase Inhibitors in Breast Cancer

115 56 6MB

The emerging use of aromatase inhibitors for endometriosis treatment

166 25 282KB

Treatment with angiotensin II in COVID-19 patients may not be beneficial

137 75 230KB

Aromatase

162 110 9MB

Offering orlistat may be opportune for obese in Italy

160 28 143KB

Further hearing screens may be required for infants

162 23 59KB

Monitoring abiraterone levels may be cost effective

171 22 184KB

Catch-22 for regulators: risk aversion may be harmful

167 7 111KB

High doses of diphenhydramine may be fatal

153 79 147KB

Nonoperative management of inflamed gallbladder may be best for elderly

168 109 79KB

The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results

111 92 710KB